Evidence map›Paper›PMID 37661812›Full record

ArticleEMBO reports2023

The polyA tail facilitates splicing of last introns with weak 3' splice sites via PABPN1.

Li Huang, Guangnan Li, Chen Du, Yu Jia, Jiayi Yang, Weiliang Fan, Yong-Zhen Xu, Hong Cheng, Yu Zhou

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Coupling of alternative splicing and alternative polyadenylation.Acta biochimica et biophysica Sinica · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Li Huang *College of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wuhan, China.ORCID 0009-0000-2023-1285
Guangnan Li *College of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wuhan, China.ORCID 0000-0001-7126-7675
Chen Du *College of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wuhan, China.ORCID 0009-0005-0969-7136
Yu JiaCollege of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wuhan, China.
Jiayi YangCollege of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wuhan, China.ORCID 0000-0003-2372-5197
Weiliang FanCollege of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wuhan, China.ORCID 0000-0003-4570-7686
Yong-Zhen XuCollege of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wuhan, China.
Hong ChengKey Laboratory of RNA Science and Engineering, Chinese Academy of Sciences, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.ORCID 0000-0002-1965-2776
Yu ZhouCollege of Life Sciences, TaiKang Center for Life and Medical Sciences, RNA Institute, Wuhan University, Wuhan, China.ORCID 0000-0002-2102-9377
Wuhan University · CNCenter for Excellence in Molecular Cell Science · CNWuhan University of Technology · CN

Funding

Fundamental Research Funds for the Central Universities 2042020kf1069Fundamental Research Funds for the Central Universities 2042022dx0003MOST ¦ National Natural Science Foundation of China (NSFC) 31871316MOST ¦ National Natural Science Foundation of China (NSFC) 31922039Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation) 2020CFA017Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation) 2020CFA057
6 · The paper itself

Abstract

The polyA tail of mRNAs is important for many aspects of RNA metabolism. However, whether and how it regulates pre-mRNA splicing is still unknown. Here, we report that the polyA tail acts as a splicing enhancer for the last intron via the nuclear polyA binding protein PABPN1 in HeLa cells. PABPN1-depletion induces the retention of a group of introns with a weaker 3' splice site, and they show a strong 3'-end bias and mainly locate in nuclear speckles. The polyA tail is essential for PABPN1-enhanced last intron splicing and functions in a length-dependent manner. Tethering PABPN1 to nonpolyadenylated transcripts also promotes splicing, suggesting a direct role for PABPN1 in splicing regulation. Using TurboID-MS, we construct the PABPN1 interactome, including many spliceosomal and RNA-binding proteins. Specifically, PABPN1 can recruit RBM26&27 to promote splicing by interacting with the coiled-coil and RRM domain of RBM27. PABPN1-regulated terminal intron splicing is conserved in mice. Together, our study establishes a novel mode of post-transcriptional splicing regulation via the polyA tail and PABPN1.

Indexed as

IntronsPoly(A)-Binding Protein IRNA-Binding ProteinsRNA Splice SitesRNA SplicingAnimalsHeLa CellsHumansMicePoly AProtein BindingRNA, MessengerPABPN1 protein, humanPoly APoly(A)-Binding Protein IRNA-Binding ProteinsRNA, MessengerRNA Splice Siteslast intron splicingPABPN1polyA tailRBM26&27weak 3′ splice site

Identifiers

PMID37661812
PMCPMC10561182
OpenAlexW4386407182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.